Health Anxiety (Parental) · Intermediate · Children and young people

Cow's Milk Protein Allergy in an Infant

Practise this SCA case with a voice-based AI patient that responds in real time — just like the real exam.

Clinical Scenario

Emily Thompson calls about her 5-month-old daughter Olivia. She is exclusively breastfeeding and suspects cow's milk protein allergy (CMPA) after reading about it online. Olivia has mild eczema (first noted at 4 months), occasional fussiness after feeds, and some loose stools. Emily has a history of eczema and hay fever herself. Olivia is growing well with no weight concerns. Emily feels guilty that her diet might be causing her baby's symptoms.

What This Case Tests

Differentiating between IgE-mediated and non-IgE-mediated CMPA; assessing the likelihood of CMPA versus normal infant symptoms; explaining the maternal elimination diet trial approach for breastfed infants; managing maternal guilt and anxiety about affecting the baby through breastfeeding; supporting continued breastfeeding as the optimal approach.

Common Mistakes Trainees Make

The three most common mistakes are: immediately diagnosing CMPA based on common infant symptoms (mild eczema and fussiness are extremely common and usually not CMPA), dismissing the mother's concerns entirely without proper assessment (the family atopy history does increase the pre-test probability), and failing to address the maternal guilt — Emily needs to hear that breastfeeding is protective and that if CMPA is present, continuing to breastfeed with dietary modification is the best treatment, not a cause for guilt.

The Consultation Challenge

This case tests clinical reasoning under pressure from a well-researched parent. CMPA is increasingly diagnosed — some argue over-diagnosed — and the SCA examiner wants to see whether you can assess the probability critically rather than either over-investigating or dismissing.

Start with a structured assessment. Olivia's symptoms need careful evaluation: the eczema (mild, noted at 4 months — common in infants with family atopy regardless of CMPA), feeding behaviour (fussiness after feeds — how often? How severe? Is she refusing the breast?), stool pattern (loose stools — how many per day? Any blood or mucus?), and growth (this is the most important indicator — is she following her centile line?).

The family atopy history (maternal eczema and hay fever) does increase the background risk, but atopy alone does not diagnose CMPA. The clinical picture here — mild eczema, occasional fussiness, some loose stools in a thriving breastfed infant — sits in the "possible but not certain" category.

The evidence-based approach for suspected non-IgE-mediated CMPA in a breastfed infant is a structured maternal elimination diet: complete removal of all cow's milk protein from Emily's diet for 2-4 weeks, then reintroduction to see if symptoms return. This is both diagnostic and therapeutic.

Address Emily's guilt directly. Many breastfeeding mothers experience intense guilt when they learn that their diet might affect their baby. Reframe this: "If Olivia does have CMPA, the fact that you're breastfeeding is actually the best possible thing — it means we can manage this through your diet while she continues to get all the benefits of breast milk. Formula-fed babies with CMPA need expensive specialist formulas."

Provide practical elimination diet guidance: what to avoid (milk, cheese, yoghurt, butter, cream, and hidden dairy in processed foods — check labels for casein, whey, lactose), calcium supplementation for Emily, and what to expect in terms of timeline (symptoms should improve within 2-4 weeks if CMPA is the cause).

Time check: Spend the first 4 minutes on a structured assessment of Olivia's symptoms and growth. By minute 6, explain your clinical reasoning — CMPA is possible but not certain, and an elimination trial is the appropriate diagnostic step. Use minutes 7-10 for the elimination diet protocol and addressing maternal guilt. Reserve the final 2 minutes for follow-up planning and safety netting.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners assess whether you take a structured allergy history: symptom timeline (did symptoms start with dairy introduction or have they been present from birth?), severity and type of symptoms (skin, GI, respiratory — single system or multi-system), growth trajectory (the most important differentiator), feeding pattern, family atopy history, and exclusion of red flags (failure to thrive, blood in stool, severe vomiting). They look for clinical reasoning — can you assess the probability of CMPA rather than just listing symptoms?

Clinical Management and Medical Complexity: Examiners expect knowledge of the elimination diet trial protocol for breastfed infants (complete maternal dairy exclusion for 2-4 weeks, then controlled reintroduction). They look for practical dietary advice (what to avoid, hidden dairy sources, calcium supplementation for the mother), a clear follow-up plan to assess response, and knowledge of when to refer (no improvement after elimination, severe symptoms, failure to thrive, IgE-mediated features requiring allergy testing). Demonstrating awareness of the MAP guideline shows depth.

Relating to Others: Examiners specifically assess whether you address the maternal guilt, whether you support continued breastfeeding rather than suggesting a switch to formula, and whether you present the elimination trial as collaborative rather than prescriptive. The mother should feel that her concerns are taken seriously and that she is doing the right thing for her baby.

Example Opening

Strong opening: "Hello Emily, I can see you're worried about Olivia and whether she might have a cow's milk allergy. I want to take your concerns seriously and go through this properly. Can you start by telling me exactly what you've been noticing with Olivia?"

When addressing the guilt: "I want to reassure you about something — if this is CMPA, it's not something you caused or could have prevented. And actually, the fact that you're breastfeeding is a real positive here, because it means we can manage this through simple dietary changes while Olivia keeps getting all the benefits of your milk."

Avoid: "These symptoms are very common in babies and probably nothing to worry about." (Dismisses legitimate concerns in a baby with family atopy risk factors).

How This Appears in the SCA

CMPA is increasingly examined in the SCA because it tests clinical reasoning — the ability to assess probability rather than jumping to diagnosis or dismissal. The breastfeeding context adds complexity around maternal diet modification and guilt. Examiners assess whether you can think critically about a popular diagnosis while respecting the parent's concerns.

Key Statistic

Cow's milk protein allergy affects approximately 2-3% of infants in the UK. However, up to 14% of parents suspect CMPA based on common infant symptoms, suggesting significant over-suspicion. Accurate assessment in primary care is essential to avoid unnecessary dietary restrictions.

Relevant Guidelines

  • NICE CG116: Food allergy in under 19s — assessment and diagnosis
  • MAP (Milk Allergy in Primary Care) guideline for management of CMPA.

Frequently Asked Questions

How do I differentiate CMPA from normal infant symptoms in the SCA?

The key differentiators are: growth trajectory (CMPA typically affects weight gain; normal infant fussiness does not), multi-system involvement (skin AND GI AND respiratory symptoms together increase probability), severity (persistent distress versus occasional fussiness), and response to dietary change. Mild eczema and occasional loose stools in a thriving infant are extremely common and usually not CMPA. Clinical reasoning, not symptom listing, is what the examiner wants to see.

What is the difference between IgE-mediated and non-IgE-mediated CMPA?

IgE-mediated CMPA causes rapid reactions (within minutes to 2 hours): urticaria, angioedema, vomiting, and rarely anaphylaxis. Non-IgE-mediated CMPA causes delayed reactions (hours to days): eczema worsening, reflux symptoms, colic, loose stools, and blood/mucus in stool. The approach differs — IgE-mediated requires allergy testing (skin prick or specific IgE), while non-IgE-mediated is diagnosed through elimination and reintroduction.

How do I explain the elimination diet to a breastfeeding mother?

Be practical and specific: remove all dairy products (milk, cheese, yoghurt, butter, cream) and check processed food labels for casein, whey, and lactose. Duration is 2-4 weeks for complete elimination before assessing response. Advise a calcium supplement (1,000mg daily) for the mother. Explain that improvement should be noticeable within 2 weeks for GI symptoms and up to 4 weeks for skin symptoms. Then plan a controlled reintroduction to confirm the diagnosis.

When should I refer rather than manage CMPA in primary care?

Refer to paediatrics or allergy services if: the infant has IgE-mediated features (immediate reactions, urticaria, angioedema), there is faltering growth or failure to thrive, symptoms are severe or involve multiple systems significantly, there is no improvement after a proper elimination trial, or the diagnosis is uncertain. In this case with mild symptoms and normal growth, primary care management with an elimination trial is appropriate first-line.

Is CMPA being over-diagnosed and does that matter for the SCA?

Yes — this is part of what the examiner is testing. Studies suggest that while 2-3% of infants truly have CMPA, up to 14% of parents suspect it. Unnecessary dairy elimination can lead to maternal nutritional deficiency, unnecessary formula prescribing (specialist formulas cost the NHS significantly), and parental anxiety. Demonstrating that you can assess probability rather than diagnose based on common symptoms alone shows the clinical reasoning the examiner values.